Experts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes

Previous Episode: Individualizing Care for Patients With Triple-Negative Breast Cancer

Next Episode: FAQs on the Use of Asparaginase Therapy in Young and Older Adults With Acute Lymphoblastic Leukemia

In this podcast, Rami Komrokji, MD; María Díez Campelo, MD, PhD; and Amer Zeidan, MBBS, MHS answer questions from an audience of healthcare professionals on topics related to personalized management of myelodysplastic syndromes including:

Practical use of the Molecular International Prognostic Scoring System Mutational targets and other treatments in ongoing clinical trialsProphylaxis with venetoclax therapyBest practices for bone marrow transplant, including induction and salvage regimensTreatment options for hypoplastic myelodysplastic syndromes

Presenters:
Rami Komrokji, MD
Professor
Department of Oncologic Sciences
University of South Florida
Vice Chair
Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida

María Díez Campelo, MD, PhD
Associate Professor
Department of Medicine
School of Medicine
University of Salamanca
Hematologist
Department of Hematology
University Hospital of Salamanca
Salamanca, Spain

Amer Zeidan, MBBS, MHS
Associate Professor, Internal Medicine
Hematology
Leader, Leukemia and Myeloid Disease Aligned Research Team (DART)
Director, Hematology Early Therapeutics Research
Yale Cancer Center and Smilow Cancer Hospital
Yale University School of Medicine
New Haven, Connecticut

Link to full program, including downloadable slidesets, expert commentaries, and on-demand webcast:
http://bit.ly/3YXgKK3

Experts Answer Questions on Personalized Management of Patients With Myelodysplastic Syndromes

CCO Oncology Podcast